CN112842935B - Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof - Google Patents

Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof Download PDF

Info

Publication number
CN112842935B
CN112842935B CN202110076944.7A CN202110076944A CN112842935B CN 112842935 B CN112842935 B CN 112842935B CN 202110076944 A CN202110076944 A CN 202110076944A CN 112842935 B CN112842935 B CN 112842935B
Authority
CN
China
Prior art keywords
carbonic acid
pet
spa
parts
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110076944.7A
Other languages
Chinese (zh)
Other versions
CN112842935A (en
Inventor
薛凯
许晶晶
彭琦霞
任平俊
郭维科
郭维学
张俊超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Petkit Network Technology Shanghai Co ltd
Original Assignee
Petkit Network Technology Shanghai Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Petkit Network Technology Shanghai Co ltd filed Critical Petkit Network Technology Shanghai Co ltd
Priority to CN202110076944.7A priority Critical patent/CN112842935B/en
Publication of CN112842935A publication Critical patent/CN112842935A/en
Application granted granted Critical
Publication of CN112842935B publication Critical patent/CN112842935B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects and a preparation method thereof. The SPA carbonic acid tablet for pets, which is related by the invention, creatively combines the effervescent agent, the adhesive, the humectant, the hair conditioner and the sterilizing and mite removing agent, and the components supplement each other and synergize synergistically, so that the problem of dry hair after the SPA carbonic acid tablet is used for pet hair can be solved; meanwhile, the pet skin deodorant has the effects of inhibiting bacteria and removing mites, and can improve the microenvironment of pet skin and reduce pet body odor.

Description

Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof
Technical Field
The invention belongs to the technical field of pet bathing products, relates to a pet SPA carbonic acid tablet and a preparation method thereof, and particularly relates to a pet SPA carbonic acid tablet with antibacterial, mite-removing and moisturizing effects and a preparation method thereof.
Background
Along with the improvement of living standard of people, more and more pets enter families, and pet bath products in the prior art are generally divided into the following types according to functions: a single-function pet bath lotion with common washing and nursing functions is a single-component composition consisting of a detergent and a hair nursing agent; a dual-function bath lotion for pet with washing, nursing, and insectifuge functions is a composite composition consisting of washing and nursing components and insectifuge components. For the second, the composition of the vermin-exterminating ingredient is divided into that of a chemical synthetic product, which often contains benzene, which is a harmful substance to the environment and causes canceration of human and animal body; the other insect killing and expelling component consists of natural herbal plant extract, and has no toxic side effect on human body and animal body in certain proportion and acting time.
Still another is effervescent carbonate tablet, SPA carbonate tablet for pet currently on the market, in which the main ingredients are sodium bicarbonate, sodium carbonate and organic acid. In the SPA bath, carbon dioxide and bicarbonate ions are released. When the carbon dioxide dissolved in the water reaches a certain content, the pet skin health care liquid has a health care effect on the pet skin. However, when SPA carbonate is used, the pet hair becomes dry in a wet state, and the pet hair is very easily broken particularly when combing wet hair. The conventional carbonic acid tablets have the main effects of deeply cleaning pet hair and enhancing skin capillary microcirculation, and have single effect.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a pet SPA carbonic acid tablet and a preparation method thereof, and particularly provides the pet SPA carbonic acid tablet with antibacterial, mite-removing and moisturizing effects and the preparation method thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
in one aspect, the invention provides a pet SPA carbonic acid tablet with bacteriostatic, mite-killing and moisturizing effects.
The pet SPA carbonic acid tablet related by the invention creatively combines the effervescent agent, the adhesive, the humectant, the hair conditioner and the sterilizing and mite removing agent, and the components supplement each other and synergize synergistically, so that the problem of dry hair after the SPA carbonic acid tablet is used for pet hair can be solved; meanwhile, the antibacterial acarid-killing pet skin care product has the functions of inhibiting bacteria and killing acarids, and can improve the microenvironment of pet skin and reduce the body odor of pets. Wherein the hair conditioner mainly has the effects of resisting static and smoothing hair; the sterilization and mite removal agent has the effects of sterilization and mite removal; the humectant mainly solves the problem of dry hair; the effervescent agent is used for releasing carbon dioxide and bicarbonate radical ions, and has health care effect on pet skin; the adhesive has the function of adhering all components, effectively blocks organic acid, sodium bicarbonate and sodium carbonate in the effervescent agent, and prevents the reaction from releasing carbon dioxide so as to ensure the stability of the product. And the components do not independently exert the respective effects, but mutually help and take effect in a crossed way. For example, moisturizers, which adsorb on the hair surface, can also play a role in antistatic. Meanwhile, through the electrostatic action, the humectant adsorbed on the hair can increase the residual quantity of the sterilizing and mite-killing agent on the hair, thereby improving the effects of inhibiting bacteria and killing mites. For another example, the small-molecule sodium hyaluronate is adopted as the humectant, so that the small-molecule sodium hyaluronate has strong permeability, can help other components to permeate, particularly helps mite-killing components to permeate to the bottom of pores, and improves mite-killing efficiency.
Preferably, the formula of the pet SPA carbonic acid tablet comprises 75-95 parts of effervescent agent, 1-10 parts of adhesive, 1-10 parts of humectant, 1-5 parts of hair conditioner and 0.1-2 parts of sterilizing and mite removing agent by weight.
When the raw materials in the pet SPA carbonic acid tablet related by the invention are combined according to the specific mass ratio, the pet SPA carbonic acid tablet has more remarkable synergistic effect on the aspects of solving the problem of drying pet hair, inhibiting bacteria and removing mites, improving the microenvironment of pet skin and the like.
The effervescent agent can be 75 parts, 78 parts, 80 parts, 82 parts, 85 parts, 88 parts, 90 parts, 92 parts, 94 parts or 95 parts by weight.
The binder may be present in 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 parts by weight.
The humectant can be 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts or 10 parts by weight and the like.
The hair conditioner can be 1 part, 2 parts, 3 parts, 4 parts or 5 parts by weight.
The weight portion of the sterilization and mite removal agent can be 0.1 portion, 0.2 portion, 0.5 portion, 0.8 portion, 1 portion, 1.2 portions, 1.5 portions, 1.8 portions or 2 portions, etc.
Other specific values within the above numerical ranges can be selected, and are not further described herein.
Preferably, the formula of the pet SPA carbonic acid tablet comprises, by weight, 85-90 parts of an effervescent agent, 3-8 parts of an adhesive, 5-10 parts of a humectant, 1-5 parts of a hair conditioner and 0.5-1 part of a sterilizing and mite-killing agent.
Preferably, the effervescent agent includes sodium bicarbonate, sodium carbonate and anhydrous citric acid.
Sodium bicarbonate, sodium carbonate and anhydrous citric acid are preferred as effervescent ingredients because the release rate of carbon dioxide, i.e. the dissolution time of the product in water, can be adjusted by changing the ratio of the three raw materials of sodium carbonate, sodium bicarbonate and citric acid, and in principle, the carbon dioxide is released slowly, and the longer the contact time between the product and the skin and the hair of the pet is, the more obvious the effect of the product is. Meanwhile, the pH value of the solution of the product completely dissolved in water can be adjusted by changing the proportion of the three components, and when the pH value is lower than 6.0, the dissolution of carbon dioxide and bicarbonate radical is not facilitated, so that the product is rapidly ineffective after being dissolved. Of course, these three raw materials are inexpensive, which is also one of the reasons.
Preferably, the mass ratio of the sodium bicarbonate to the sodium carbonate to the citric acid is (5-10) to 1 (1-2).
The mass ratio of the sodium bicarbonate to the sodium carbonate to the citric acid is specially selected to be (5-10) to 1 (1-2) because the pH value of the solution of the product after being completely dissolved in water needs to be controlled, and the pH value of the solution should not be lower than 6.0.
The specific point value in the (5-10) may be 5, 6, 7, 8, 9 or 10, and other specific point values in the range may be selected, which is not described herein again.
The specific values in (1-2) may be 1, 1.2, 1.4, 1.5, 1.6, 1.7, 1.8, or 2, and other specific values in the range may be selected, which is not described herein again.
Preferably, the binder comprises any one or a combination of at least two of PEG, sodium sulphate, poloxamer, polysorbate or sodium dodecylbenzene sulphonate.
The combination of at least two of the above-mentioned compounds, such as the combination of PEG and sodium sulfate, the combination of poloxamer and sodium sulfate, the combination of polysorbate and sodium dodecyl sulfate, etc., can be selected in any combination manner, and are not repeated herein.
Preferably, the number average molecular weight of the PEG is 6000-.
Preferably, the binder is a combination of PEG and sodium sulfate.
PEG and sodium sulfate are preferred as the binder in the carbonic acid tablet related by the invention because PEG can be melted at high temperature to wrap organic acid particles; the sodium sulfate can further effectively prevent the organic acid particles coated by the PEG from contacting with the sodium carbonate and the sodium bicarbonate.
Preferably, the mass ratio of the PEG to the sodium sulfate is (2-4):1, for example, 2:1, 3:1 or 4:1, and other specific points within the range can be selected, which is not described herein again.
Preferably, the humectant comprises any one or a combination of at least two of fibroin, anhydrous betaine, sodium hyaluronate, trehalose, taurine, algal polysaccharides or xylitol.
The combination of at least two of the above-mentioned components, such as the combination of fibroin and anhydrous betaine, the combination of sodium hyaluronate and trehalose, the combination of trehalose and taurine, etc., can be selected in any other combination manner, and is not repeated herein.
Preferably, the number average molecular weight of the sodium hyaluronate is 10000-500000, such as 10000, 50000, 100000, 200000, 300000, 400000, 500000, and the like, and other specific values within the range can be selected, which is not described herein again.
Preferably, the humectant is a combination of fibroin, anhydrous betaine, sodium hyaluronate, trehalose and taurine.
The humectant in the carbonic acid tablet according to the present invention is preferably fibroin, anhydrous betaine, sodium hyaluronate, trehalose, and taurine because these humectants are in the form of solid powder at normal temperature and do not contain bound water, and thus can be used in products such as effervescent carbonic acid tablets.
Preferably, the mass ratio of the fibroin, the anhydrous betaine, the sodium hyaluronate, the trehalose and the taurine is (5-15): (15-25):1 (15-25): 5-15).
The specific point value in the (5-15) may be 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, etc., and other specific point values in the range may be selected, which is not described herein again.
The specific point values in the (15-25) may be 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, etc., and other specific point values in the range may be selected, which is not described herein again.
Preferably, the hair conditioning agent comprises any one of lysine hydrochloride, serine, glycine, sodium glutamate or aspartic acid or a combination of at least two thereof.
The combination of at least two of the above-mentioned compounds, such as the combination of lysine hydrochloride and serine, the combination of serine and glycine, the combination of glycine and sodium glutamate, etc., can be selected in any combination manner, and are not described in detail herein.
Preferably, the hair conditioning agent is a combination of lysine hydrochloride and serine.
Lysine hydrochloride and serine are preferred as the hair conditioner in the carbonic acid tablet, which is related by the invention, because serine has better smoothing effect on the skin and hair of pets than other amino acids; and lysine hydrochloride contains two carboxyl in the molecular structure, so that the antistatic effect is better.
Preferably, the mass ratio of lysine hydrochloride to serine is 1:2-2:1, such as 1:2, 1:1 or 2:1, and other specific values in the range can be selected, which are not described in detail herein.
Preferably, the bactericidal and acaricidal agent comprises one or a combination of at least two of matrine, cymene phenol, 2, 4-dichlorobenzyl alcohol or nisin.
The combination of at least two of the matrine and nisin, cymene phenol and nisin, matrine and 2, 4-dichlorobenzyl alcohol, etc. can be selected in any combination manner, and are not repeated herein.
Preferably, the bactericidal and acaricidal agent is a combination of matrine and nisin.
The bactericidal and acaricidal agent in the carbonic acid tablet is preferably the combination of the matrine and the nisin because the matrine and the nisin are anhydrous substances, so the bactericidal and acaricidal agent is suitable for products such as carbonic acid effervescent tablets, has good water solubility, can be quickly dissolved in water, and synergistically plays a role in killing microorganisms.
Preferably, the mass ratio of the matrine to the nisin is (1-3):1, for example, 1:1, 2:1 or 3:1, etc., and other specific values within the range can be selected, which is not described in detail herein.
In the present invention, after 10 to 20g (e.g., 10g, 12g, 15g, 18g, or 20 g) of the pet SPA carbonate tablets are dissolved in 1L of distilled water, the pH of the solution is 6.0 to 6.5 (e.g., 6.0, 6.1, 6.2, 6.3, 6.4, or 6.5). Because the solubility of carbon dioxide and bicarbonate can be ensured under the condition, when the pH value is lower than 6.0, carbon dioxide and bicarbonate are difficult to exist in a large amount in water, so that the product effect is poor.
In another aspect, the invention provides a preparation method of the pet SPA carbonate tablet with antibacterial, mite-killing and moisturizing effects, wherein the preparation method comprises the following steps:
heating, mixing and stirring part of the adhesive and acid components in the effervescent agent, and cooling; mixing the mixture with other residual raw materials, and pressing to obtain the final product; the partial adhesive is 10-90% of the total adhesive mass.
The preparation method of the pet SPA carbonic acid tablet related by the invention is simple and easy to operate, and is very suitable for large-scale industrial production.
Preferably, the heating is to heat to 50-60 ℃, for example, 50 ℃, 52 ℃, 55 ℃, 58 ℃ or 60 ℃, and other specific values in the range can be selected, and are not described in detail herein.
Preferably, the temperature is reduced to below 15 ℃, for example, 15 ℃, 12 ℃, 10 ℃, 8 ℃, 7 ℃, 6 ℃, 5 ℃ or 4 ℃ and the like, and other specific values in the range can be selected, which is not described herein again.
Preferably, the mixing with the rest of the raw materials is performed in an environment with a humidity of less than 20%, for example, a humidity of 20%, 15%, 10%, or 5%, and other specific values within the range can be selected, and thus, detailed description thereof is omitted.
Compared with the prior art, the invention has the following beneficial effects:
the pet SPA carbonic acid tablet related by the invention creatively combines the effervescent agent, the adhesive, the humectant, the hair conditioner and the sterilizing and mite removing agent, and the components supplement each other and synergize synergistically, so that the problem of dry hair after the SPA carbonic acid tablet is used for pet hair can be solved; meanwhile, the pet skin deodorant has the effects of inhibiting bacteria and removing mites, and can improve the microenvironment of pet skin and reduce pet body odor.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following further describes the technical solution of the present invention with reference to the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
Example 1
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which comprises the following components in percentage by mass: 67% sodium bicarbonate, 10% sodium carbonate, 10.3% anhydrous citric acid, 3% PEG-6000, 1% anhydrous sodium sulfate, 1% fibroin, 2% trehalose, 2% anhydrous betaine, 1% taurine, 0.1% sodium hyaluronate (number average molecular weight 30000), 1% lysine hydrochloride, 1% serine, 0.4% matrine, 0.2% nisin.
The preparation method comprises the following steps:
(1) firstly, PEG-6000 and anhydrous citric acid are heated and stirred uniformly at 55 ℃ under the anhydrous condition, and then the temperature is reduced to 15 ℃;
(2) then uniformly mixing the product obtained in the step (1) with other raw materials in an environment with the temperature of 15 ℃ and the humidity of 10%;
(3) and (3) finally pressing the product of the step (2) into a sheet shape under high pressure.
Example 2
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which comprises the following components in percentage by mass: 67% sodium bicarbonate, 10% sodium carbonate, 10.3% anhydrous citric acid, 4% PEG-8000, 1% anhydrous sodium sulfate, 1% fibroin, 1.5% trehalose, 1.5% anhydrous betaine, 1% taurine, 0.1% sodium hyaluronate (number average molecular weight 50000), 1% lysine hydrochloride, 0.5% serine, 0.6% matrine, 0.5% nisin.
The preparation method comprises the following steps:
(1) firstly, PEG-8000 and anhydrous citric acid are heated and stirred uniformly at 50 ℃ under the anhydrous condition, and then the temperature is reduced to 10 ℃;
(2) then uniformly mixing the product obtained in the step (1) with other raw materials in an environment with the temperature of 10 ℃ and the humidity of 15%;
(3) and (3) finally, pressing the product of the step (2) into a sheet shape under high pressure.
Example 3
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which comprises the following components in percentage by mass: 67% sodium bicarbonate, 10% sodium carbonate, 10.3% anhydrous citric acid, 2% PEG-8000, 1% anhydrous sodium sulfate, 1% fibroin, 2.5% trehalose, 2.5% anhydrous betaine, 1% taurine, 0.1% sodium hyaluronate (number average molecular weight 80000), 0.5% lysine hydrochloride, 1% serine, 0.7% matrine, 0.4% nisin.
The preparation method comprises the following steps:
(1) firstly, PEG-8000 and anhydrous citric acid are heated and stirred uniformly at 60 ℃ under the anhydrous condition, and then the temperature is reduced to 10 ℃;
(2) then uniformly mixing the product obtained in the step (1) with other raw materials in an environment with the temperature of 10 ℃ and the humidity of 20 percent;
(3) and (3) finally pressing the product of the step (2) into a sheet shape under high pressure.
Example 4
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which is different from the composition formula of the pet SPA carbonic acid tablet in the embodiment 1 only in that matrine is not contained, and the addition amount of nisin is 0.6%. The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 5
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which is different from the composition formula of the pet SPA carbonic acid tablet in the embodiment 1 only in that nisin is not contained, and the addition amount of matrine is 0.6%. The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 6
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, mite-killing and moisturizing effects, and the composition formula of the pet SPA carbonic acid tablet is different from that of the pet SPA carbonic acid tablet in the embodiment 1 only in that the type of a bactericidal mite-killing agent is replaced by 0.6 percent of 2, 4-dichlorobenzyl alcohol. The other components and contents are all kept unchanged. The preparation method is as in example 1.
Example 7
The embodiment provides a pet SPA carbonate tablet with bacteriostatic, mite-killing and moisturizing effects, and the composition formula of the pet SPA carbonate tablet is different from that of the pet SPA carbonate tablet in embodiment 1 only in that lysine hydrochloride is not contained, and the addition amount of serine is 2%. The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 8
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, which is prepared according to a formula which is different from that of the pet SPA carbonic acid tablet in the embodiment 1 only in that serine is not contained, and the addition amount of lysine hydrochloride is 2%. The other components and contents are kept unchanged. The preparation method is referred to example 1.
Example 9
This example provides a pet SPA carbonate tablet with bacteriostatic, acarid-removing and moisturizing effects, which is different from the pet SPA carbonate tablet in example 1 only in that the type of hair conditioner is replaced with 2% algal polysaccharide. The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 10
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, and the composition formula of the pet SPA carbonic acid tablet is only different from that of the pet SPA carbonic acid tablet in the embodiment 1 in that the moisturizing agents are 2.5% of trehalose, 2.5% of anhydrous betaine, 1% of taurine and 0.1% of sodium hyaluronate (the number average molecular weight is 30000). The other components and contents are all kept unchanged. The preparation method is as in example 1.
Example 11
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, and the composition formula of the pet SPA carbonic acid tablet is different from that of the pet SPA carbonic acid tablet in the embodiment 1 only in that the moisturizing agents are 1% of fibroin, 2.5% of trehalose, 2.5% of anhydrous betaine and 0.1% of sodium hyaluronate (the number average molecular weight is 30000). The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 12
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects, and the composition formula of the pet SPA carbonic acid tablet is only different from that of the pet SPA carbonic acid tablet in the embodiment 1 in that the moisturizing agents are 1.1% of fibroin, 2% of trehalose, 2% of anhydrous betaine and 1% of taurine. The other components and contents are kept unchanged. The preparation method is as in example 1.
Example 13
The embodiment provides a pet SPA carbonic acid tablet with bacteriostatic, mite-killing and moisturizing effects, and the composition formula of the pet SPA carbonic acid tablet is only different from that of the pet SPA carbonic acid tablet in the embodiment 1 in that the addition amount of PEG-6000 is 4% and anhydrous sodium sulfate is not contained. The other components and contents are all kept unchanged. The preparation method is as in example 1.
Comparative example 1
The comparative example provides a pet SPA carbonate tablet, which is different from example 1 only in that it does not contain humectant components, i.e., 1% fibroin, 2% trehalose, 2% anhydrous betaine, 1% taurine, 0.1% sodium hyaluronate (number average molecular weight 30000), and the reduced amount is added to each raw material in the mass ratio of other raw materials. The preparation method is as in example 1.
Comparative example 2
The comparative example provides a pet SPA carbonic acid tablet, the composition formula of which is different from that of example 1 only in that no hair conditioner component, namely 1% lysine hydrochloride and 1% serine is contained, and the reduced amount is added into each raw material according to the mass ratio of other raw materials. The preparation method is as in example 1.
Comparative example 3
The comparative example provides a pet SPA carbonic acid tablet, and the composition formula of the pet SPA carbonic acid tablet is only different from that of the pet SPA carbonic acid tablet in example 1 in that the pet SPA carbonic acid tablet does not contain the components of the sterilization and mite removal agent, namely 0.4% of matrine and 0.2% of nisin, and the reduction amount is added into each raw material according to the mass ratio of other raw materials. The preparation method is as in example 1.
Evaluation test:
(1) evaluation of bacteriostatic Effect
20g of the solid products obtained in examples 1-13 and comparative examples 1-3 were completely dissolved in 1L of distilled water according to QB/T2738-2012 test, and the solution was tested within 1 hour and the time of action with the microorganisms was 10 min. Results of bacteriostatic rate are shown in table 1:
TABLE 1
Figure BDA0002907939680000111
Figure BDA0002907939680000121
From the results in Table 1, it can be seen that: the bactericidal and acaricidal agent has the greatest influence on the bacteriostatic rate of the product, but other components also have influence on the bacteriostatic rate of the product. Such as amino acid components and sodium hyaluronate components, can help the bactericidal acarus-killing agent penetrate into cell membranes of human microorganisms, thereby enhancing the bacteriostatic action.
(2) Evaluation of mite-killing Effect
The result of the mite killing rate measured according to the method of NY/T1151.2-2006 is shown in Table 2:
TABLE 2
Figure BDA0002907939680000122
Figure BDA0002907939680000131
From the results of table 2, it can be seen that: the sterilization and mite removal agent has the greatest influence on the mite removal rate of the product; meanwhile, the combination of the matrine and the nisin has better mite killing effect; and other components have a synergistic effect on the mite killing rate.
(3) Evaluation of Hair moisturizing Effect
The moisturizing effect of the product on hair is measured by a gravimetric method:
one healthy jock summer-haired dog had its back hair selected as a sample. Clean once with neutral shampoo (1.0% strength) and rinse three times with clear water. Then soaked in a carbonic acid bath (20g of the products of examples 1-13 and comparative examples 1-3 completely dissolved in 1L of purified water) for 10min, rinsed with clear water for 0.5min, and then dried in an oven at 30 ℃ for 24 h.
Putting the sample into a drying dish of which the humidity is strictly controlled to be 80% and saturated KCl solution for 12 hours, and weighing the mass m 1 Then the sample is placed in saturated CaCl 2 After the solution is strictly controlled in a drying dish with the humidity of 26% for 12 hours, the mass m is weighed 2 And finally calculating the water loss R. R ═ m 1 -m 2 )/m 1 ×100%。
In the present method, a smaller hair moisture loss amount R indicates a better moisturizing ability.
The results are shown in Table 3.
TABLE 3
Figure BDA0002907939680000132
Figure BDA0002907939680000141
The test results are shown in table 3: the moisture retention agent can obviously reduce the moisture loss of the hair in a dry environment, and the hair conditioner and the moisture retention agent have obvious synergistic effect.
(4) Evaluation of Hair antistatic Effect
Referring to GB/T16801, the surface specific resistance method is adopted to test the antistatic effect of the hair:
one healthy jock summer-haired dog had its back hair selected as a sample. After the sample was cleaned with neutral shampoo (1.0% strength), it was rinsed three times with clean water. And then soaked in a carbonic acid bath (20g of the products of examples 1 to 13 and comparative examples 1 to 3 were completely dissolved in 1L of purified water) for 10min, washed with clean water for 0.5min to be clean, and oven-dried at 30 ℃. In the test, the temperature was 20 ℃ and the relative humidity was 26%. The antistatic property, namely the resistance value Deltalg rhos, was measured. The lower this value, the lower the resistance, the better the antistatic properties.
TABLE 4
Group of △lgρs
Example 1 0.80
Example 2 0.92
Example 3 0.86
Example 4 0.82
Example 5 0.82
Example 6 0.83
Example 7 0.96
Example 8 0.90
Example 9 1.05
Example 10 0.85
Example 11 0.84
Example 12 0.82
Example 13 0.80
Comparative example 1 0.92
Comparative example 2 1.34
Comparative example 3 0.82
The test results are shown in table 4: hair conditioners play a key role in the antistatic effect of hair, but moisturizers synergistically enhance the antistatic effect, probably because the hydrophilic groups of the moisturizers adsorbed on the hair are directed to the air, which accelerates the conduction of static charges. Therefore, the conditioner and the humectant have obvious synergistic effect on antistatic effect.
The applicant states that the invention is illustrated by the above examples, but the invention is not limited to the above examples, that is, the invention does not mean that the invention must be implemented by the above examples. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
The preferred embodiments of the present invention have been described in detail, however, the present invention is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present invention within the technical idea of the present invention, and these simple modifications are within the protective scope of the present invention.
It should be noted that the various technical features described in the above embodiments can be combined in any suitable manner without contradiction, and the invention is not described in any way for the possible combinations in order to avoid unnecessary repetition.

Claims (8)

1. The pet SPA carbonic acid tablet with the effects of bacteriostasis, mite removal and moisture preservation is characterized in that the formula of the pet SPA carbonic acid tablet comprises 75-95 parts of effervescent agent, 1-10 parts of adhesive, 1-10 parts of humectant, 1-5 parts of hair conditioner and 0.1-2 parts of sterilizing and mite removal agent;
the effervescent agent consists of sodium bicarbonate, sodium carbonate and anhydrous citric acid;
the adhesive is a combination of PEG and sodium sulfate in a mass ratio of (2-4):1, and the number average molecular weight of the PEG is 6000-10000;
the humectant is a combination of fibroin, anhydrous betaine, sodium hyaluronate, trehalose and taurine in a mass ratio of (5-15): 15-25):1 (15-25): 5-15, and the number average molecular weight of the sodium hyaluronate is 10000-500000;
the hair conditioner is a combination of lysine hydrochloride and serine in a mass ratio of 1:2-2: 1;
the sterilization and mite removal agent is a combination of matrine and nisin in a mass ratio of (1-3) to 1.
2. The pet SPA carbonic acid tablet with the effects of bacteriostasis, mite killing and moisturizing as claimed in claim 1, wherein the formula of the pet SPA carbonic acid tablet comprises, by weight, 85-90 parts of an effervescent agent, 3-8 parts of an adhesive, 5-10 parts of a humectant, 1-5 parts of a hair conditioner and 0.5-1 part of a sterilizing mite killing agent.
3. The pet SPA carbonic acid tablet with bacteriostatic, acaricidal and moisturizing effects as claimed in claim 1, wherein the mass ratio of the sodium bicarbonate to the sodium carbonate to the anhydrous citric acid is (5-10) to (1) to (2).
4. The pet SPA carbonate tablet with antibacterial, acaricidal and moisturizing effects as claimed in claim 1, wherein after 10-20g of the pet SPA carbonate tablet is dissolved in 1L of distilled water, the pH value of the solution is 6.0-6.5.
5. The preparation method of the pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects as claimed in any one of claims 1 to 4, wherein the preparation method comprises the following steps:
heating, mixing and stirring part of the adhesive and acid components in the effervescent agent, and cooling; mixing the mixture with other residual raw materials, and pressing to obtain the final product;
the partial adhesive is 10-90% of the total adhesive mass.
6. The method for preparing pet SPA carbonate tablets with antibacterial, acaricidal and moisturizing effects as claimed in claim 5, wherein the heating is heating to 50-60 ℃.
7. The preparation method of the pet SPA carbonic acid tablet with bacteriostatic, acarid-removing and moisturizing effects as claimed in claim 5, wherein the temperature reduction refers to the temperature reduction below 15 ℃.
8. The method for preparing pet SPA carbonic acid tablet with antibacterial, acaricidal and moisturizing effects as claimed in claim 5, wherein the mixing with the rest of other raw materials is carried out in an environment with humidity less than 20%.
CN202110076944.7A 2021-01-20 2021-01-20 Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof Active CN112842935B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110076944.7A CN112842935B (en) 2021-01-20 2021-01-20 Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110076944.7A CN112842935B (en) 2021-01-20 2021-01-20 Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof

Publications (2)

Publication Number Publication Date
CN112842935A CN112842935A (en) 2021-05-28
CN112842935B true CN112842935B (en) 2022-09-13

Family

ID=76007866

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110076944.7A Active CN112842935B (en) 2021-01-20 2021-01-20 Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112842935B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113499294B (en) * 2021-08-03 2023-07-21 媞颂日化用品(广州)有限公司 Plant composition for cats with skin and hair care effects and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105726423B (en) * 2016-05-11 2018-12-04 于文 Concentrated type pet detergent and preparation method thereof
CN106667808A (en) * 2016-12-10 2017-05-17 钦州学院 Detergent for pet and preparation method of detergent
CN111249173B (en) * 2020-01-20 2021-04-06 小佩网络科技(上海)有限公司 Deodorizing and purifying concentrated solution and preparation method and application thereof
CN111110577B (en) * 2020-02-27 2023-01-31 广州玥颜化妆品有限公司 Mild mite-removing itching-relieving shower gel and preparation method thereof
CN111671699A (en) * 2020-04-10 2020-09-18 上海兰轩新黛日用化学品科技有限公司 Safe and efficient sterilization type pet shampoo
CN112136837A (en) * 2020-09-25 2020-12-29 上海和黄白猫有限公司 Antibacterial mite-killing composition, antibacterial mite-killing laundry detergent and preparation method thereof

Also Published As

Publication number Publication date
CN112842935A (en) 2021-05-28

Similar Documents

Publication Publication Date Title
CN103540455B (en) Natural fruit perfumed soap and preparation method thereof
CN109536296A (en) A kind of baby's antibacterial biological detergent and preparation method thereof
JP2002316909A (en) Functional material
CN104789383A (en) Antibacterial washing liquid
CN102618399A (en) Composite capable of removing pesticide residue and disinfecting and preparation method thereof
CN106085627A (en) A kind of natural environmental-protective cleaning agent
CN112842935B (en) Pet SPA carbonic acid tablet with antibacterial, mite-killing and moisturizing effects and preparation method thereof
CN102872471B (en) Sterilizing deodorant of refrigerator
CN112137913A (en) Washing-free disinfection gel and preparation method thereof
JP3610278B2 (en) Processed rice bran
CN105733853A (en) Sun block and repair sea buckthorn fruit cold-processed handmade soap and preparing method thereof
CN102251438B (en) Antiseptic fragrant paper towel and manufacturing method thereof
CN106635485A (en) Toilet sterilizing deodorant and preparation method thereof
CN102405937B (en) Probiotic composite bactericide for improving microecology of animal house and body surface of animal and application method thereof
CN112891262A (en) Hand sanitizer and preparation method thereof
CN106591011B (en) A kind of antibacterial soap and preparation method thereof
CN101020072B (en) Deodorizing bacteriostatic mildewproof powder preparation
CN108125798A (en) A kind of mild disposable foam liquid soap with bacteria resistance function
CN113637454A (en) Natural herbal anti-mite anti-static bacteriostatic dust remover
CN109602667B (en) Antibacterial hand sanitizer and preparation method thereof
CN101993788A (en) Healthy zero-carbon washing powder and preparation method thereof
CN104381326A (en) Anti-mold sterilization aromatic bead
CN110511836A (en) A kind of cleaning milk dirt, cleaning and sterilizing piece of spot and preparation method thereof
CN105381454A (en) Nasal cavity wetting agent containing trehalose
CN115869223A (en) Deodorizing and mite-killing cleaning agent and cleaning wet tissue applying same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant